LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.031623
 31.62 84.90 744 2449 0.3037 0.5644
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 31.62 84.90 955 2449 0.3898 0.6470
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 33.32 84.90 1024 2722 0.3761 0.6449
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 33.32 84.90 1074 2722 0.3945 0.6607
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 33.32 84.90 757 2722 0.2781 0.5486
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 33.32 84.90 929 2722 0.3412 0.6132
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 35.03 84.90 1045 2991 0.3494 0.6299
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 35.03 84.90 1082 2991 0.3617 0.6409
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 35.03 84.90 785 2991 0.2624 0.5416
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 35.03 84.90 950 2991 0.3176 0.5999
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 36.73 84.90 1077 3254 0.3310 0.6208
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 36.73 84.90 1114 3254 0.3423 0.6313
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 36.73 84.90 902 3254 0.2772 0.5671
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 36.73 84.90 975 3254 0.2996 0.5905
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 38.43 84.90 1119 3459 0.3234 0.6195
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 38.43 84.90 1156 3459 0.3341 0.6294
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 38.43 84.90 876 3459 0.2532 0.5471
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 38.43 84.90 925 3459 0.2674 0.5629
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 40.14 84.90 1110 3682 0.3015 0.6043
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 40.14 84.90 1146 3682 0.3112 0.6137
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 40.14 84.90 879 3682 0.2387 0.5369
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 40.14 84.90 941 3682 0.2556 0.5563
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 41.84 84.90 1105 4003 0.2760 0.5866
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 41.84 84.90 1139 4003 0.2845 0.5953
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 41.84 84.90 896 4003 0.2238 0.5279
MN20160318_Q02
F10